Cleared Special

K090696 - NUVANT CARDIAC EVENT MONITORING SYSTEM (FDA 510(k) Clearance)

Also includes:
NUVANT MOBILE CARDIAC TELEMETRY SYSTEM

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K090696 · Corventis, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2009
Decision
95d
Days
Class 2
Risk

K090696 is an FDA 510(k) clearance for the NUVANT CARDIAC EVENT MONITORING SYSTEM. Classified as Outpatient Cardiac Telemetry (product code QYX), Class II - Special Controls.

Submitted by Corventis, Inc. (San Jose, US). The FDA issued a Cleared decision on June 19, 2009 after a review of 95 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Corventis, Inc. devices

Submission Details

510(k) Number K090696 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 16, 2009
Decision Date June 19, 2009
Days to Decision 95 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 125d · This submission: 95d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QYX Outpatient Cardiac Telemetry
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
Definition Devices Are Intended To Continuously Record And Analyze Electrocardiograms For Automatic Detection And Recording Of Cardiac Electrical Activity In An Outpatient Setting. Detected, Notifiable Events Are Transmitted To The Prescribing Clinician During The Monitoring Period By A 24/7 Attended Analysis Center After Review By A Qualified Individual. Devices May Allow Remote Access And Display Of Electrocardiograms Acquired. Not For Use For Detection Or Notification Of Hemodynamically Unstable Or Life-threatening Arrhythmias Or Cardiac Events Requiring Urgent Medical Response. Not Intended For Patients At Elevated Risk Of Serious Cardiovascular Events That Would Require Prompt Intervention. It Is Not Intended For Monitoring Patients During Cardiac Rehabilitation Outside Of Healthcare Facilities. Devices Are Intended For Prescription Use Only.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - QYX Outpatient Cardiac Telemetry

All 20
Devices cleared under the same product code (QYX) and FDA review panel - the closest regulatory comparables to K090696.
RhythmStar System (SL)
K250793 · RhythMedix, LLC · Apr 2026
Rhythm Express Remote Cardiac Monitoring System (RX-1 mini)
K241179 · Vivaquant, Inc. · Jul 2025
SmartCardia 7L Platform (MCT)
K240653 · Smartcardia SA · Oct 2024
Zio AT® device (A100A1001)
K240029 · iRhythm Technologies, Inc. · Oct 2024
RhythmStar System
K233584 · RhythMedix, LLC · Jul 2024